New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 7, 2021 - The FDA approved Daré Bioscience’s Xaciato (clindamycin) vaginal gel, for the treatment of bacterial vaginosis (BV) in females 12 years and older.
Download PDF
Return to publications
